Latest Conference Articles

Optogenetic therapy for retinal degeneration shows potential of gene-independent therapeutic strategies

Optogenetic therapy for retinal degeneration shows potential of gene-independent therapeutic strategies

September 10th 2021, 1:00pm

EURETINA

During a presentation at the EURETINA 2021 Virtual Congress, Dr José-Alain Sahel explains that optogenetics involves the use of artificial photoreceptors from specific retinal cells to restore vision by transferring a gene that encodes for a light-sensitive protein that causes neuronal cells to respond to light stimulation.

Comparison of suitable naïve versus pretreated DMO patients

Comparison of suitable naïve versus pretreated DMO patients

September 10th 2021, 12:46pm

EURETINA

Dr Javier Zarranz-Ventura discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pretreated DMO patients, and what it means for future research.

Should NPDR patients be treated with anti-VEGF agents?

Should NPDR patients be treated with anti-VEGF agents?

September 9th 2021, 6:07pm

EURETINA

Dr Jennifer Sun explores the question of whether ophthalmologists should be using anti-VEGF agents to treat patients with nonproliferative diabetic retinopathy (NPDR).

Exploration of new biological treatments in posterior uveitis

Exploration of new biological treatments in posterior uveitis

September 9th 2021, 4:23pm

EURETINA

Professor Quan Dong Nguyen speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.

Addressing roadblocks of treating peripheral hemorrhagic polypoidal choroidal vasculopathy

Addressing roadblocks of treating peripheral hemorrhagic polypoidal choroidal vasculopathy

September 9th 2021, 12:20pm

EURETINA

Treating the disease can be a challenge, and at the EURETINA 2021 Virtual Congress, Dr Chekitaan Singh discussed a case study detailing the care of a patient who had already lost vision in one eye from a similar issue.

Study investigates PCR risks associated with intravitreal injections for AMD

Study investigates PCR risks associated with intravitreal injections for AMD

September 9th 2021, 8:25am

EURETINA

Speaking during the EURETINA 2021 Virtual Congress, Dr Marta Belmonte-Grau discussed the potential risk for posterior capsular rupture during cataract surgery.

EURETINA 2021 offers myriad educational opportunities for retina specialists

EURETINA 2021 offers myriad educational opportunities for retina specialists

August 19th 2021, 7:01am

EURETINA

The EURETINA 2021 Virtual Meeting is scheduled for September 9 to 12, 2021, and retina specialists are eager to see the showcase of cutting-edge scientific developments.

Registration open: EURETINA 2021 virtual programme covers 4 days, 5 channels

Registration open: EURETINA 2021 virtual programme covers 4 days, 5 channels

August 18th 2021, 11:45am

EURETINA

Programming includes 16 EURETINA sessions; 22 symposia; 44 instructional courses; 85 hours of content, and more than 300 speakers.

Focusing on 24-month data of the PALADIN study

Focusing on 24-month data of the PALADIN study

May 7th 2021, 9:01pm

ARVO

Dr Michael A. Singer speaks on the highlights of his presentation focusing on IOP in the PALADIN 24-month data intravitreal steroid (ILUVIEN).

Injections offer relief for refractory severe noninfectious keratitis

Injections offer relief for refractory severe noninfectious keratitis

May 7th 2021, 1:35pm

ARVO

Joseph Grieco, PhD, notes that treatment fills a gap for patients who are unresponsive to the standard treatments for noninfectious keratitis.